UPDATE 1-St. Jude's profit beats estimates on heart rhythm device sales

July 16 (Reuters) - St. Jude Medical Inc reported higher-than-expected quarterly earnings and revenue, largely due to increased sales of its devices to treat abnormal heart rhythms.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.